Patent ID: 11952594
Assignee: ELIGO BIOSCIENCE
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 3:
4. The pharmaceutical composition according to claim 1, wherein the nucleic sequence of interest is selected from the group consisting of a Cas nuclease, a Cas9 nuclease, a guide RNA, a CRISPR locus, a toxin, a gene expressing a nuclease or a kinase, a TALEN, a ZFN, a meganuclease, a recombinase, a bacterial receptor, a membrane protein, a structural protein, a secreted protein, a gene expressing resistance to an antibiotic or to a drug, a gene expressing a toxic protein or a toxic factor, and a gene expressing a virulence protein or a virulence factor or any combination thereof.